Melanoma targeting: locating the spot.
D000970:Antineoplastic Agents / Q000493:pharmacokinetics / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000032:analysis; D004337:Drug Carriers; D006801:Humans; D008545:Melanoma / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy; D008751:Methylene Blue / Q000008:administration & dosage; D011355:Prodrugs / Q000493:pharmacokinetics / Q000627:therapeutic use; D011868:Radioisotopes / Q000008:administration & dosage / Q000627:therapeutic use; D011979:Receptors, Pituitary Hormone / Q000032:analysis; D012878:Skin Neoplasms / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy
D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; D004337:Drug Carriers; D011355:Prodrugs; D011868:Radioisotopes; D011979:Receptors, Pituitary Hormone; C029446:MSH receptor; D008751:Methylene Blue